Assembly Biosciences Inc
Statements
Cash Flow
Assembly Biosciences Inc (ASMB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.9 | -11 | 35 | -12 | -11 | -9.8 | -16 | -16 | -17 | -17 | -24 | -21 | -19 | -21 | -25 | -23 | 11 | -25 | -33 | -22 | -19 | -19 | -28 | -18 | -20 | -19 | -23 | -14 | -14 | 74 | -18 | -17 | -15 | -0.4 | -23 | -17 | -15 | 14 | -22 | -15 | -38 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.1 | 1.0 | 1.2 | 2.0 | 2.6 | 2.8 | 4.1 | 12 | 6.0 | 6.8 | 6.6 | 2.1 | 5.4 | 6.5 | 4.9 | 7.1 | 6.0 | 3.7 | -0.3 | 2.0 | 1.6 | 1.9 | 1.4 | 1.6 | 1.6 | 2.0 | 1.8 | 1.2 | 1.1 | 1.0 | 0.7 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 1.7 | 1.5 | 1.1 | 2.4 | 6.7 | |
| 1.3 | 0.9 | 1.4 | 2.3 | 2.7 | -6.1 | 4.1 | 12 | 5.8 | 7.9 | 7.8 | 3.2 | 6.5 | 6.9 | 6.1 | 8.3 | 7.2 | 7.3 | 2.5 | 2.2 | 2.5 | 42 | 2.5 | 2.5 | 2.4 | 2.9 | 2.7 | 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.4 | -0.4 | 47 | -1.1 | -1.4 | -0.7 | -3.5 | -1.1 | -1.4 | 1.8 | -4.2 | -5.2 | 0.1 | -0.2 | -4.6 | -39 | 6.6 | 6.5 | -8.8 | -1.4 | -2.8 | 1.6 | -7.0 | 3.9 | 0.8 | 0.2 | -7.2 | 1.3 | -1.2 | 83 | -9.2 | -6.2 | -6.0 | 9.4 | -15 | -7.3 | -7.2 | -8.7 | -14 | -14 | -43 | |
| 0.0 | 0.1 | 0.1 | 0.0 | 0.5 | 0.4 | 0.0 | 0.1 | 0.0 | 0.2 | 1.5 | 0.1 | 1.5 | 0.0 | 0.1 | 0.4 | 0.0 | 1.8 | 3.1 | 3.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 11 | 16 | 6.7 | -19 | -1.5 | -1.7 | -1.1 | 1.5 | -74 | -62 | 11 | 25 | 7.8 | -95 | 21 | 77 | -50 | 21 | 18 | -3.1 | 20 | -8.5 | 33 | 9.6 | 31 | 17 | 10 | -8.4 | 19 | -90 | 17 | 5.1 | 24 | -6.7 | 6.6 | 17 | -158 | 21 | -5.4 | -92 | -235 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.2 | 0.6 | 0.1 | 0.3 | 66 | 1.5 | 1.8 | 156 | 0.6 | 0.1 | 0.7 | 1.4 | 137 | 0.1 | 1.0 | 0.8 | 5.7 | 34 | 6.2 | 10 | – | – | – | – | 0.6 | 4.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.2 | 0.6 | 0.1 | 0.3 | 66 | 1.5 | 1.9 | 156 | 0.6 | 0.1 | 0.7 | 1.4 | 137 | 0.1 | 1.0 | 0.8 | 5.7 | 34 | 6.2 | 10 | 2.7 | 0.2 | 0.2 | 0.1 | 0.4 | 4.5 | 0.1 | 0.0 | 9.2 | 0.0 | 12 | 0.0 | 17 | 1.9 | 0.4 | 172 | 0.5 | 0.1 | 109 | 281 | |
| 3.5 | 4.8 | 42 | -31 | -12 | 55 | -15 | -13 | 66 | -78 | -12 | 5.2 | -9.4 | 22 | -4.4 | 54 | -38 | 1.1 | 19 | -19 | 11 | -25 | 5.5 | -8.1 | 12 | -2.3 | -8.9 | -22 | 5.0 | -6.8 | -1.1 | 0.5 | 9.2 | 9.9 | -15 | 0.6 | -1.5 | 36 | -27 | 1.2 | 8.3 | |
| -7.9 | -11 | 35 | -12 | -11 | -10 | -16 | -16 | -17 | -17 | -25 | -21 | -19 | -21 | -25 | -24 | 11 | -27 | -36 | -22 | -19 | -19 | -28 | -18 | -20 | -19 | -23 | -14 | -14 | 74 | -18 | -17 | -15 | -0.4 | -23 | -17 | -15 | 14 | -22 | -15 | -39 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.